Dr. Bradley Robert Prestidge, MD

Dr. Prestidge practices at Baptist Health Louisville in Louisville, Kentucky, part of Baptist Health.

Dr. Prestidge's NPI, 1134126220, was assigned on July 5, 2005. Dr. Prestidge graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 1985. Dr. Prestidge holds Illinois license 036168260.

Dr. Prestidge's primary practice is Baptist Health Louisville, at 4000 Kresge Way, Louisville, KY 40207 in Jefferson County. The practice phone is (502) 897-8100.

Dr. Prestidge's primary practice is Baptist Health Louisville in Louisville, Kentucky, part of Baptist Health. Dr. Prestidge is also affiliated with OSF Saint Francis Medical Center. The medical group on file is Carle Physician Group. Dmand AI also links Dr. Prestidge to 4 more hospitals, 4 medical groups and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Prestidge practices, 7 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Prestidge's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Prestidge is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Prestidge's licenses on file in 12 states: Illinois, California, Kentucky, Ohio, Colorado, Minnesota, Texas, Alabama, New Mexico, Virginia, Indiana and Washington.

Dmand AI lists breast cancer radiation and lung cancer radiation among the conditions Dr. Prestidge treats.

CMS data shows 294 Medicare services from Dr. Prestidge across 7 procedure codes in 2024, for 91 Medicare patients. Medicare paid $13,770 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 91 Medicare patients who saw Dr. Prestidge in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have cancer, and 69% have high cholesterol. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Prestidge's median patient age at 74, with 32% women.

In 2024, Dr. Prestidge wrote 29 Medicare Part D claims for 16 patients. 90% of them were for generic drugs. CMS names the drug for 17 of them, across 1 drug with 11 or more claims each, at $291 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Prestidge for performance year 2024, reported as part of a group. Dr. Prestidge accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 43 papers to Dr. Prestidge, published from 2007 to 2023. 2013 was the busiest year, with 2. The most frequent topics are Brachytherapy, Prostatic Neoplasms and Radiotherapy Dosage. Dr. Prestidge has published most often in Int J Radiat Oncol Biol Phys. Dr. Prestidge's most frequent co-authors are Thomas A. Buchholz, MD, Steven J. Frank, MD and Richard G. Stock, MD.

Dmand AI links Dr. Prestidge to 1 clinical trial. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 161 general payments to Dr. Prestidge from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 32% of the total. IsoRay, Inc paid the most, $27,355.

Dmand AI lists 1 award for Dr. Prestidge, most recently Fellow in 2017.

Dr. Prestidge graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 1985. Dr. Prestidge is a member of AOA, American Brachytherapy Society, ACR, AMA and ASTRO.

Dr. Prestidge is in network with 17 carriers, including Aetna, HCSC and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.